DOES A NEGATIVE D-DIMER EXCLUDE THROMBOSIS

被引:8
作者
EISENBERG, PR
机构
基金
美国国家卫生研究院;
关键词
D O I
10.1016/0268-9499(93)90046-X
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:32 / 35
页数:4
相关论文
共 23 条
[1]  
ALEXOPOULOS D, 1991, J AM COLL CARDIOL, V17, P868
[2]   TREATMENT OF PROSTHETIC TRICUSPID-VALVE THROMBOSIS WITH LOW-DOSE TISSUE PLASMINOGEN-ACTIVATOR [J].
COHEN, ML ;
BARZILAI, B ;
GUTIERREZ, F ;
JAFFE, AS ;
EISENBERG, P .
AMERICAN HEART JOURNAL, 1990, 120 (04) :978-980
[3]  
COLLEN D, 1981, THROMB HAEMOSTASIS, V45, P77
[4]   INFLUENCE OF THE FAST-ACTING INHIBITOR OF PLASMINOGEN-ACTIVATOR ON INVIVO THROMBOLYSIS INDUCED BY TISSUE-TYPE PLASMINOGEN-ACTIVATOR IN RABBITS - INTERFERENCE OF TISSUE-DERIVED COMPONENTS [J].
COLUCCI, M ;
PARAMO, JA ;
STASSEN, JM ;
COLLEN, D .
JOURNAL OF CLINICAL INVESTIGATION, 1986, 78 (01) :138-144
[5]  
DECLERCK PJ, 1987, THROMB HAEMOSTASIS, V58, P1024
[6]  
DEFOUW NJ, 1988, FIBRINOLYSIS, V2, P235
[7]  
DEITCHER S, 1993, IN PRESS AM J MED
[8]   ELEVATED CONCENTRATIONS OF CROSS-LINKED FIBRIN DEGRADATION PRODUCTS IN PLASMA - AN EARLY MARKER OF GRAM-NEGATIVE BACTEREMIA [J].
DEITCHER, SR ;
EISENBERG, PR .
CHEST, 1993, 103 (04) :1107-1112
[9]   RELATIONSHIP BETWEEN ELEVATED PLASMA-LEVELS OF CROSS-LINKED FIBRIN DEGRADATION PRODUCTS (XL-FDP) AND THE CLINICAL PRESENTATION OF PATIENTS WITH MYOCARDIAL-INFARCTION [J].
EISENBERG, PR ;
SHERMAN, LA ;
PEREZ, J ;
JAFFE, AS .
THROMBOSIS RESEARCH, 1987, 46 (01) :109-120
[10]   VALIDITY OF ENZYME-LINKED IMMUNOSORBENT ASSAYS OF CROSS-LINKED FIBRIN DEGRADATION PRODUCTS AS A MEASURE OF CLOT LYSIS [J].
EISENBERG, PR ;
JAFFE, AS ;
STUMP, DC ;
COLLEN, D ;
BOVILL, EG .
CIRCULATION, 1990, 82 (04) :1159-1168